Geneva Capital Management LLC Sells 36,271 Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Geneva Capital Management LLC lessened its holdings in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 7.0% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 480,145 shares of the company’s stock after selling 36,271 shares during the period. Geneva Capital Management LLC’s holdings in Ryan Specialty were worth $30,806,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of the business. Sanctuary Advisors LLC boosted its holdings in shares of Ryan Specialty by 1.2% during the 4th quarter. Sanctuary Advisors LLC now owns 15,690 shares of the company’s stock valued at $1,045,000 after buying an additional 188 shares in the last quarter. State of Alaska Department of Revenue boosted its holdings in shares of Ryan Specialty by 1.6% during the 4th quarter. State of Alaska Department of Revenue now owns 12,130 shares of the company’s stock valued at $778,000 after buying an additional 190 shares in the last quarter. CIBC Asset Management Inc boosted its holdings in shares of Ryan Specialty by 5.6% during the 4th quarter. CIBC Asset Management Inc now owns 3,674 shares of the company’s stock valued at $236,000 after buying an additional 196 shares in the last quarter. Loomis Sayles & Co. L P boosted its holdings in shares of Ryan Specialty by 26.3% during the 3rd quarter. Loomis Sayles & Co. L P now owns 1,373 shares of the company’s stock valued at $91,000 after buying an additional 286 shares in the last quarter. Finally, Exchange Traded Concepts LLC boosted its holdings in shares of Ryan Specialty by 2.6% during the 4th quarter. Exchange Traded Concepts LLC now owns 11,760 shares of the company’s stock valued at $755,000 after buying an additional 295 shares in the last quarter. Institutional investors own 84.82% of the company’s stock.

Insider Transactions at Ryan Specialty

In other news, Director Nicholas Dominic Cortezi sold 35,000 shares of the stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $66.71, for a total value of $2,334,850.00. Following the transaction, the director now owns 60,200 shares in the company, valued at $4,015,942. This represents a 36.76 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders have sold 316,451 shares of company stock worth $20,907,793 in the last quarter. Company insiders own 11.10% of the company’s stock.

Ryan Specialty Price Performance

RYAN opened at $70.77 on Thursday. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. The stock has a market capitalization of $18.53 billion, a P/E ratio of 102.56, a P/E/G ratio of 1.19 and a beta of 0.72. The company’s 50-day simple moving average is $66.36 and its two-hundred day simple moving average is $67.53. Ryan Specialty Holdings, Inc. has a 52-week low of $48.48 and a 52-week high of $75.97.

Ryan Specialty (NYSE:RYAN) last posted its earnings results on Thursday, February 20th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.02). The company had revenue of $663.53 million for the quarter, compared to the consensus estimate of $658.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. As a group, analysts predict that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current year.

Ryan Specialty Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Tuesday, March 4th will be paid a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 0.68%. The ex-dividend date is Tuesday, March 4th. This is a boost from Ryan Specialty’s previous quarterly dividend of $0.11. Ryan Specialty’s dividend payout ratio is 69.57%.

Analyst Ratings Changes

A number of analysts have recently commented on RYAN shares. Keefe, Bruyette & Woods dropped their target price on shares of Ryan Specialty from $77.00 to $76.00 and set an “outperform” rating on the stock in a report on Friday, February 21st. UBS Group increased their price objective on shares of Ryan Specialty from $82.00 to $84.00 and gave the company a “buy” rating in a research report on Wednesday, February 26th. Barclays increased their price objective on shares of Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a research report on Thursday, November 21st. Morgan Stanley assumed coverage on shares of Ryan Specialty in a research report on Thursday, December 5th. They set an “overweight” rating and a $90.00 price objective on the stock. Finally, Wells Fargo & Company increased their price objective on shares of Ryan Specialty from $64.00 to $69.00 and gave the company an “equal weight” rating in a research report on Friday, February 21st. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and six have given a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $75.27.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.